Juvenile Idiopathic Arthritis News and Research

RSS
Juvenile idiopathic arthritis (JIA) is the name given to a group of conditions characterized by joint inflammation or arthritis, occurring first before the age of 16.
Study: Repurposed arthritis drug did not improve outcomes of patients with severe COVID-19 pneumonia

Study: Repurposed arthritis drug did not improve outcomes of patients with severe COVID-19 pneumonia

Juvenile inflammatory rheumatic disease associated with higher antibody responses to seasonal coronaviruses

Juvenile inflammatory rheumatic disease associated with higher antibody responses to seasonal coronaviruses

HSS presents research related to rheumatology and orthopedic surgery at 2020 ACR annual meeting

HSS presents research related to rheumatology and orthopedic surgery at 2020 ACR annual meeting

Longer period of morning stiffness reported in children from less affluent families

Longer period of morning stiffness reported in children from less affluent families

New guideline for juvenile idiopathic arthritis gives emphasis to disease-modifying treatments

New guideline for juvenile idiopathic arthritis gives emphasis to disease-modifying treatments

Survey: Only few children with rheumatic diseases report contracting COVID-19

Survey: Only few children with rheumatic diseases report contracting COVID-19

Repurposing immunosuppressants to manage COVID-19

Repurposing immunosuppressants to manage COVID-19

Lancet issues correction on paper than prompted WHO to suspend Hydroxychloroquine trial

Lancet issues correction on paper than prompted WHO to suspend Hydroxychloroquine trial

Children with COVID-19 presenting with sudden severe lung disease

Children with COVID-19 presenting with sudden severe lung disease

Higher prevalence of anxiety disorders in youth with chronic medical conditions

Higher prevalence of anxiety disorders in youth with chronic medical conditions

Arthritis drug assessed as potential treatment for COVID-19-related pneumonia

Arthritis drug assessed as potential treatment for COVID-19-related pneumonia

Juvenile immune arthritis – new treatments wanted

Juvenile immune arthritis – new treatments wanted

Optimal therapy for Down syndrome arthropathy remains unclear, reveals study

Optimal therapy for Down syndrome arthropathy remains unclear, reveals study

Study shows ADA2 is a sensitive, specific biomarker for macrophage activation syndrome

Study shows ADA2 is a sensitive, specific biomarker for macrophage activation syndrome

Additional medications needed to control the symptoms of juvenile idiopathic arthritis

Additional medications needed to control the symptoms of juvenile idiopathic arthritis

Children with Down syndrome at greater risk of an associated form of arthritis

Children with Down syndrome at greater risk of an associated form of arthritis

Early detection, treatment may reduce risk of death from systemic JIA-associated lung disease

Early detection, treatment may reduce risk of death from systemic JIA-associated lung disease

ACR and Arthritis Foundation release two guidelines on juvenile idiopathic arthritis

ACR and Arthritis Foundation release two guidelines on juvenile idiopathic arthritis

Inflammatory arthritis may impact intimacy, sexual function for men and women

Inflammatory arthritis may impact intimacy, sexual function for men and women

Machine learning offers hope for improved diagnosis, treatment of children with juvenile arthritis

Machine learning offers hope for improved diagnosis, treatment of children with juvenile arthritis